Real-world comparison between weekly versus biweekly dosing of cetuximab for metastatic colorectal cancer

por Aggarwal, Himani, Han, Yimei, Sheffield, Kristin M, Cui, Zhanglin Lin
Publicado 2023

Primary tumor location and survival in colorectal cancer: A retrospective cohort study

por Aggarwal, Himani, Sheffield, Kristin M, Li, Li, Lenis, David, Sorg, Rachael, Barzi, Afsaneh, Miksad, Rebecca
Publicado 2020

Development and Validation of Coding Algorithms to Identify Patients with Incident Non-Small Cell Lung Cancer in United States Healthcare Claims Data

por Beyrer, Julie, Nelson, David R, Sheffield, Kristin M, Huang, Yu-Jing, Lau, Yiu-Keung, Hincapie, Ana L
Publicado 2023

The Burden of Metastatic Cancer–Induced Bone Pain: A Narrative Review

por Colosia, Ann, Njue, Annete, Bajwa, Zahid, Dragon, Erika, Robinson, Rebecca L, Sheffield, Kristin M, Thakkar, Sheena, Richiemer, Steven H
Publicado 2022

Clinicogenomic factors and treatment patterns among patients with advanced non–small cell lung cancer with or without brain metastases in the United States

por Smyth, Emily Nash, John, Jincy, Tiu, Ramon V, Willard, Melinda Dale, Beyrer, Julie Kay, Bowman, Lee, Sheffield, Kristin M, Han, Yimei, Brastianos, Priscilla K
Publicado 2023

Characteristics and Outcomes in Cases of US Male Patients with Metastatic Breast Cancer Receiving Abemaciclib in Routine Clinical Practice

por Ring, Alistair, Karuturi, Meghan, Smyth, Emily Nash, Lokhandwala, Tasneem, Sheffield, Kristin M., Willey, Joanne, Lunacsek, Orsolya, Sapunar, Francisco, Cui, Zhanglin Lin, Coutinho, Anna, Rybowski, Sarah
Publicado 2023

Perceptions of overdetection of breast cancer among women 70 years of age and older in the USA: a mixed-methods analysis

por Pappadis, Monique R, Volk, Robert J, Krishnan, Shilpa, Weller, Susan C, Jaramillo, Elizabeth, Hoover, Diana Stewart, Giordano, Sharon H, Tan, Alai, Sheffield, Kristin M, Housten, Ashley J, Goodwin, James S
Publicado 2018

Real-world survival outcomes of heavily pretreated patients with refractory HR+, HER2−metastatic breast cancer receiving single-agent chemotherapy—a comparison with MONARCH 1

por Rugo, Hope S., Dieras, Veronique, Cortes, Javier, Patt, Debra, Wildiers, Hans, O’Shaughnessy, Joyce, Zamora, Esther, Yardley, Denise A., Carter, Gebra Cuyun, Sheffield, Kristin M., Li, Li, Andre, Valerie A. M., Li, Xiaohong I., Frenzel, Martin, Huang, Yu-Jing, Dickler, Maura N., Tolaney, Sara M.
Publicado 2020